Share This
The FINANCIAL A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.
Many people recovering from COVID-19 suffer from long-term symptoms of lung damage, including breathlessness, coughing, fatigue and limited ability to exercise.
COVID-19 can lead to inflammation in the lungs due to the infection and the immune system’s reaction to it. The inflammation may improve over time, but in some people it persists.
Lung inflammation and scarring
In severe cases, the lungs may become scarred. The scarring causes stiffness in the lungs, which can make it difficult to breathe and get oxygen to the bloodstream, resulting in long-term breathlessness and difficulty managing daily tasks.
A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19.
The study, launched with £2 million of funding from UK Research and Innovation (UKRI) and led by Imperial College London, aims to develop treatment strategies and prevent disability.
Breathlessness is a big problem for many people with long-COVID, particularly on exertion. For people with more severe lung scarring, this can be a devastating disease. Professor Gisli Jenkins Study lead
Many recovering COVID-19 patients suffer from long-term symptoms of lung damage, including breathlessness, coughing, fatigue and limited ability to exercise.
COVID-19 can lead to inflammation in the lungs due to the infection and the immune system’s reaction to it. The inflammation may improve over time, but in some people it persists.
Date Time
New national study of long-term impacts of lung damage from COVID-19
A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19.
The study, launched with £2 million of funding from UK Research and Innovation (UKRI) and led by Imperial College London, aims to develop treatment strategies and prevent disability.
Breathlessness is a big problem for many people with long-COVID, particularly on exertion. For people with more severe lung scarring, this can be a devastating disease. Professor Gisli Jenkins Study lead
Many recovering COVID-19 patients suffer from long-term symptoms of lung damage, including breathlessness, coughing, fatigue and limited ability to exercise.
Share This
The FINANCIAL An international research team led by Oxford University scientists has developed a portable test for antibodies that fight the novel coronavirus that causes COVID-19.
The test, which spots the presence of virus-fighting antibodies rather than a coronavirus infection, can be adapted to work on blood from a finger prick – making it quick and easy to use. The research team, which includes scientists from Taiwan, India, Thailand and France, as well as UK university and NHS researchers, trialled the test on patients with COVID-19, but now hope to adapt it to identify those who have successfully generated antibodies after a vaccine, versus those who may need a booster, Oxford University notes.